You just read:

Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis

News provided by

Proteostasis Therapeutics, Inc.

May 08, 2018, 07:00 ET